NCT02009527View on ClinicalTrials.gov

Arginase Inhibition in Ischemia-reperfusion Injury

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

September 30, 2013

Conditions
Coronary Artery DiseaseType 2 Diabetes Mellitus
Interventions
DRUG

N-hydroxy-nor-arginine

DRUG

NaCl

Trial Locations (1)

17176

Karolinska Institutet, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT02009527 - Arginase Inhibition in Ischemia-reperfusion Injury | Biotech Hunter | Biotech Hunter